[
  {
    "sentence": "The workflow for the 3 parts of the experiment is displayed in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Optimal alignment of the chicken eye was assumed when the image of the pupil in the left screen window was centered and the scan of the fundal layers in the right window was horizontally aligned (for examples, see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The approximate lateral distance between each of the five measurement positions within each image was 80 µm, covering a total lateral distance of about 320 µm (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The workflow for the 3 parts of the experiment is displayed in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The workflow for the 3 parts of the experiment is displayed in Figure 1.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Optimal alignment of the chicken eye was assumed when the image of the pupil in the left screen window was centered and the scan of the fundal layers in the right window was horizontally aligned (for examples, see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The approximate lateral distance between each of the five measurement positions within each image was 80 µm, covering a total lateral distance of about 320 µm (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Optimal alignment of the chicken eye was assumed when the image of the pupil in the left screen window was centered and the scan of the fundal layers in the right window was horizontally aligned (for examples, see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The approximate lateral distance between each of the five measurement positions within each image was 80 µm, covering a total lateral distance of about 320 µm (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Optimal alignment of the chicken eye was assumed when the image of the pupil in the left screen window was centered and the scan of the fundal layers in the right window was horizontally aligned (for examples, see Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "The approximate lateral distance between each of the five measurement positions within each image was 80 µm, covering a total lateral distance of about 320 µm (Figure 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Baclofen Temporarily Reduced Choroidal Thickness in Eyes with Normal Visual Input\nChoroidal thickness in eyes injected with 25 µg baclofen decreased significantly after 6 and 8 h compared to the baseline level (6 h: 162.9 ± 10.0 µm vs. 215.3 ± 16.7 µm, p = 0.0006; 8 h: 167.4 ± 9.3 µm vs. 215.3 ± 16.7 µm, p = 0.002, Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Choroidal thickness in eyes injected with 25 µg baclofen decreased significantly after 6 and 8 h compared to the baseline level (6 h: 162.9 ± 10.0 µm vs. 215.3 ± 16.7 µm, p = 0.0006; 8 h: 167.4 ± 9.3 µm vs. 215.3 ± 16.7 µm, p = 0.002, Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The control eyes in the DM model injected with either saline or baclofen showed no differences in the development of refractive errors and eye lengths (Figure 4A–C).",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "Panel A",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The effect of baclofen on choroidal thickness in +7D lens-wearing eyes was thus very different from that in eyes treated with saline and positive lenses (+7D lens: saline vs. baclofen: 4.71 ± 4 µm vs. −78.19 ± 14.10 µm, p = 0.0002, Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In contrast, retinal thickness increased with positive lens treatment in both baclofen- and saline-injected +7D-lens treated eyes (+7D vs. fellow: saline: 7.54 ± 2.86 µm vs. −3.83 ± 2.96 µm, p = 0.003; baclofen: 1.34 ± 3.87 µm vs. −4.75 ± 3,17 µm, p = 0.01, Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When myopia was induced with diffusers or negative lenses, both the choroid and retina became significantly thinner in experimental eyes than in fellow eyes (Figure 5A,B,D,E); baclofen injections had no additional effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There was also no significant difference in the cartilage or fiber layer thickness between the experimental and fellow eyes in either the DM (Figure 5G,J) or LIM (Figure 5H,K) groups.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The eyes that wore a positive lens had a thicker cartilage sclera than the fellow eyes (+7D vs. no lens: saline group: 8.95 ± 2.85 µm vs. 0.42 ± 2.43 µm, p = 0.004; baclofen group: 11.20 ± 3.62 µm vs. −2.56 ± 3.73 µm, p = 0.02, Figure 5I) and a significant thinner fibrous layer (+7D vs fellow: saline group: 6.89 ± 1.37 µm vs. 11.88 ± 1.92 µm, p = 0.05; baclofen group: 6.60 ± 1.79 µm vs 16.64 ± 1.68 µm, p = 0.02, Figure 5L).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel L",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The effect of baclofen on choroidal thickness in +7D lens-wearing eyes was thus very different from that in eyes treated with saline and positive lenses (+7D lens: saline vs. baclofen: 4.71 ± 4 µm vs. −78.19 ± 14.10 µm, p = 0.0002, Figure 5C).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel C",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "In contrast, retinal thickness increased with positive lens treatment in both baclofen- and saline-injected +7D-lens treated eyes (+7D vs. fellow: saline: 7.54 ± 2.86 µm vs. −3.83 ± 2.96 µm, p = 0.003; baclofen: 1.34 ± 3.87 µm vs. −4.75 ± 3,17 µm, p = 0.01, Figure 5F).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel F",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "When myopia was induced with diffusers or negative lenses, both the choroid and retina became significantly thinner in experimental eyes than in fellow eyes (Figure 5A,B,D,E); baclofen injections had no additional effect.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel A",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "There was also no significant difference in the cartilage or fiber layer thickness between the experimental and fellow eyes in either the DM (Figure 5G,J) or LIM (Figure 5H,K) groups.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel G",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel H",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The eyes that wore a positive lens had a thicker cartilage sclera than the fellow eyes (+7D vs. no lens: saline group: 8.95 ± 2.85 µm vs. 0.42 ± 2.43 µm, p = 0.004; baclofen group: 11.20 ± 3.62 µm vs. −2.56 ± 3.73 µm, p = 0.02, Figure 5I) and a significant thinner fibrous layer (+7D vs fellow: saline group: 6.89 ± 1.37 µm vs. 11.88 ± 1.92 µm, p = 0.05; baclofen group: 6.60 ± 1.79 µm vs 16.64 ± 1.68 µm, p = 0.02, Figure 5L).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel I",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel L",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Baclofen Reduced Retinal Dopamine Metabolism in the Three Ametropia Models\nConsistent with previous findings [44,45], the vitreal DOPAC level, which is considered a sensitive measure of DA release from the retina, was severely reduced in deprived and negative lens-treated eyes (Figure 6A,B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This effect was further enhanced via an injection of baclofen (saline vs. baclofen: DM: 3.43 ± 0.31 ng/100 mg vs. 1.81 ± 0.13 ng/100 mg, p < 0.0001; LIM: 2.16 ± 0.17 ng/100 mg vs. 1.11 ± 0.08 ng/100 mg, p = 0.0006, Figure 6A,B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Baclofen also reduced vitreal DOPAC levels in the fellow eyes (DM: saline-injected vs. baclofen-injected contralateral control eye: 5.87 ± 0.29 ng/100 mg vs. 3.90 ± 0.22 ng/100 mg, p < 0.0001; LIM: non-injected contralateral control eye saline group vs. baclofen group: 3.96 ± 0.23 ng/100 mg vs. 2.97 ± 0.16 ng/100 mg, p = 0.001, Figure 6A,B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In addition, vitreal dopamine levels were also lower in baclofen-injected eyes compared to saline-injected eyes (diffuser-treated eyes: saline vs. baclofen: 0.33 ± 0.07 ng/100 mg vs. 0.02 ± 0.01 ng/100 mg, p = 0.0004; control eyes: 0.48 ± 0.10 ng/100 mg vs. 0.18 ± 0.04 ng/100 mg, p = 0.0005, Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In negative lens-treated chickens, the vitreal HVA concentration in the fellow eyes was significantly lower in the baclofen group (saline vs. baclofen: 3.66 ± 0.20 ng/100 mg vs. 2.86 ± 0.20 ng/100 mg, p = 0.006, Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Additionally, the retinal DOPAC concentration in −7D lens-wearing eyes was reduced after injection of the GABABR agonist baclofen (saline vs. baclofen: 0.44 ± 0.02 ng/mg protein vs. 0.29 ± 0.03 ng/mg protein, p = 0.009, Figure 6K).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel K",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "It is important to note that dopamine metabolism was decreased in all fellow eyes in the baclofen groups, regardless of whether the fellow eyes themselves were injected with baclofen (Exp 2., fellow eyes of deprived chickens, Figure 6A,D) or were not injected (Exp.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "3, fellow eyes of LIM chickens, Figure 6B,H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Binocular differences were analyzed with paired t-test. ns: not significant; *: p < 0.05; **: p < 0.01; ***: p < 0.001; ****: p < 0.0001.Similar to the two myopia models, retinal dopamine release and metabolism were reduced also in +7D lens-wearing eyes (Figure 6C,F,I,L), despite the fact that eye growth changed in the opposite direction.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "It decreased the content of DOPAC and dopamine in the vitreous to an even larger extent (+7D lens-treated eyes: saline vs. baclofen: vitreal DOPAC: 2.80 ± 0.17 ng/100 mg vs. 2.09 ± 0.05 ng/100 mg, p = 0.004; vitreal dopamine: 0.17 ± 0.02 ng/100 mg vs. 0.07 ± 0.01 ng/100 mg, p = 0.004, Figure 6C,F).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Consistent with previous findings [44,45], the vitreal DOPAC level, which is considered a sensitive measure of DA release from the retina, was severely reduced in deprived and negative lens-treated eyes (Figure 6A,B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "This effect was further enhanced via an injection of baclofen (saline vs. baclofen: DM: 3.43 ± 0.31 ng/100 mg vs. 1.81 ± 0.13 ng/100 mg, p < 0.0001; LIM: 2.16 ± 0.17 ng/100 mg vs. 1.11 ± 0.08 ng/100 mg, p = 0.0006, Figure 6A,B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Baclofen also reduced vitreal DOPAC levels in the fellow eyes (DM: saline-injected vs. baclofen-injected contralateral control eye: 5.87 ± 0.29 ng/100 mg vs. 3.90 ± 0.22 ng/100 mg, p < 0.0001; LIM: non-injected contralateral control eye saline group vs. baclofen group: 3.96 ± 0.23 ng/100 mg vs. 2.97 ± 0.16 ng/100 mg, p = 0.001, Figure 6A,B).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In addition, vitreal dopamine levels were also lower in baclofen-injected eyes compared to saline-injected eyes (diffuser-treated eyes: saline vs. baclofen: 0.33 ± 0.07 ng/100 mg vs. 0.02 ± 0.01 ng/100 mg, p = 0.0004; control eyes: 0.48 ± 0.10 ng/100 mg vs. 0.18 ± 0.04 ng/100 mg, p = 0.0005, Figure 6D).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel D",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "In negative lens-treated chickens, the vitreal HVA concentration in the fellow eyes was significantly lower in the baclofen group (saline vs. baclofen: 3.66 ± 0.20 ng/100 mg vs. 2.86 ± 0.20 ng/100 mg, p = 0.006, Figure 6H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel H",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Additionally, the retinal DOPAC concentration in −7D lens-wearing eyes was reduced after injection of the GABABR agonist baclofen (saline vs. baclofen: 0.44 ± 0.02 ng/mg protein vs. 0.29 ± 0.03 ng/mg protein, p = 0.009, Figure 6K).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel K",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "It is important to note that dopamine metabolism was decreased in all fellow eyes in the baclofen groups, regardless of whether the fellow eyes themselves were injected with baclofen (Exp 2., fellow eyes of deprived chickens, Figure 6A,D) or were not injected (Exp.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel A",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "3, fellow eyes of LIM chickens, Figure 6B,H).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel B",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "Similar to the two myopia models, retinal dopamine release and metabolism were reduced also in +7D lens-wearing eyes (Figure 6C,F,I,L), despite the fact that eye growth changed in the opposite direction.",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  },
  {
    "sentence": "It decreased the content of DOPAC and dopamine in the vitreous to an even larger extent (+7D lens-treated eyes: saline vs. baclofen: vitreal DOPAC: 2.80 ± 0.17 ng/100 mg vs. 2.09 ± 0.05 ng/100 mg, p = 0.004; vitreal dopamine: 0.17 ± 0.02 ng/100 mg vs. 0.07 ± 0.01 ng/100 mg, p = 0.004, Figure 6C,F).",
    "figure_references": [
      {
        "figure_number": "Figure 6",
        "panel": "Panel C",
        "figure_key": "figure_6"
      }
    ]
  }
]